Carregant...
Bevacizumab for progressive glioblastoma multiforme: a case of treading the tightrope
Until March 2013, Bevacizumab had been funded through the National Cancer Drugs Fund (CDF) for the treatment of recurrent/progressive Glioblastoma multiforme (GBM). Although the CDF concluded at the time that there was insufficient evidence around the effectiveness of the Bevacizumab on overall surv...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791690/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox238.094 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|